Condition

COPD: Causes, Spirometry Staging & Treatment

COPD is a chronic, progressive lung condition causing irreversible airflow obstruction. It's largely caused by smoking but highly manageable with the right treatment plan.2

Written by Suman Konda, Clinical Pharmacist · Based on peer-reviewed sources · Editorial policy · Not medical advice

Last reviewed and updated: · How we check our content

UK prevalence
~1.2 million diagnosed
Smoking causes
~85% of COPD cases
Spirometry defines it
FEV₁/FVC <0.70 post-bronchodilator
Pulmonary rehab
Most effective non-drug intervention

Quick answer

COPD is a progressive lung condition causing irreversible airflow obstruction, largely caused by smoking but highly manageable. Spirometry — not symptoms or X-ray — makes the diagnosis, and since the 2023 GOLD revision, treatment is driven by symptoms and exacerbation history rather than the spirometry number alone.

What COPD is

Advertisement

COPD (chronic obstructive pulmonary disease) is a chronic, progressive lung condition in which narrowed, damaged airways and loss of lung elastic recoil cause persistent airflow limitation. Smoking causes about 85% of cases, but about 15% occur in never-smokers — from alpha-1 antitrypsin deficiency, occupational dust or chemical exposure, or biomass cooking-fire smoke.2

It cannot currently be cured, but it is highly manageable: the right treatment plan slows progression, cuts exacerbations and improves daily life. A key distinction from asthma is reversibility — asthma's airflow limitation largely reverses with bronchodilators, while COPD's is fixed.

How COPD is usually evaluated

COPD cannot be diagnosed on symptoms or X-ray alone: spirometry (lung function testing) is required. The key diagnostic number is the FEV1/FVC ratio — the forced expiratory volume in one second divided by the total exhaled volume. In healthy lungs FEV1 is at least 70% of FVC; in COPD the ratio falls below 0.70 after bronchodilator use, because obstruction reduces FEV1 disproportionately.

GOLD stageSeverityFEV1 (% predicted)Typical symptoms
GOLD 1Mild≥80%Cough, mild breathlessness on exertion
GOLD 2Moderate50–79%Increased breathlessness; may limit activities
GOLD 3Severe30–49%Significant breathlessness; frequent exacerbations
GOLD 4Very severe<30%Very severe breathlessness; poor quality of life

Blood tests support assessment and guide exacerbation care: a full blood count (chronic low oxygen can raise red cell count; anaemia worsens breathlessness and is common), arterial blood gas for oxygen and CO2 levels, alpha-1 antitrypsin level to rule out hereditary deficiency, and CRP or procalcitonin during exacerbations to help distinguish bacterial from viral triggers.34 A bronchodilator reversibility test separates COPD from asthma: COPD shows minimal improvement after salbutamol, asthma typically shows significant improvement.

Your next steps after a COPD diagnosis

Diagnosis is the start of a management plan. Work through these with your doctor:

  1. Stop smoking — the highest-impact step. It is the only intervention that slows disease progression, and it helps at any stage. Ask about cessation support rather than going it alone.
  2. Confirm the spirometry picture. Make sure the diagnosis rests on post-bronchodilator spirometry, and ask your GOLD stage — then remember that symptoms and exacerbation history, not the FEV1 number, now drive treatment choices.
  3. Ask about pulmonary rehabilitation. An 8–12 week programme of exercise, education and breathing techniques reduces breathlessness and hospital readmissions — among the most effective non-drug interventions available.1
  4. Get a written exacerbation action plan. Know your warning signs — increased breathlessness, change in sputum colour (green/yellow suggests infection), worsening cough — and what to do first when they appear.
  5. Discuss oxygen and vaccinations. Long-term oxygen therapy is for resting oxygen saturation below about 92% on air; ask too about flu and pneumococcal vaccination, since respiratory infections trigger exacerbations.
  6. Know when it is urgent. Seek urgent care for severe breathlessness unrelieved by reliever inhalers, blue lips, confusion, or inability to complete sentences.

How COPD severity is graded

Spirometry both confirms COPD and grades it. A post-bronchodilator FEV1/FVC ratio below 0.70 confirms persistent airflow limitation; the FEV1 percentage of predicted then sets the GOLD grade:

GOLD gradeFEV1 (% of predicted)What it means
GOLD 1 – mild80% or moreEarly airflow limitation; symptoms may be minimal
GOLD 2 – moderate50–79%Breathlessness on exertion typical; most commonly diagnosed stage
GOLD 3 – severe30–49%Greater limitation; exacerbations more frequent
GOLD 4 – very severeBelow 30%Severe limitation; may need oxygen assessment

Treatment grouping also weighs exacerbation history and symptom scores, not the spirometry number alone. Arterial blood gas is reserved mainly for moderate-to-severe disease to assess oxygen and carbon dioxide levels.

These are approximate bands, not quotes: prices vary by city and lab. Where possible, choose a NABL-accredited lab.

Practical notes

A simple symptom diary pays off: note breathlessness, cough and sputum changes, how often you reach for your reliever inhaler, and any flare-ups with their dates. Doctors use this record to judge whether your treatment is working and when to step it up.

Come prepared with your smoking history (how much, for how long, when you quit), any long-term exposure to dust, fumes or indoor cooking smoke, your vaccination status, and a list of other conditions — heart disease in particular, since it shares symptoms with COPD.

Smoking cessation is the single most important step your doctor will discuss — quitting slows the decline in lung function at any stage. Pulmonary rehabilitation programmes, regular walking as advised, flu and pneumococcal vaccines, and learning correct inhaler technique are the other pillars worth discussing.

Spirometry is usually repeated about once a year, or sooner if your symptoms change. Many doctors also give you a written action plan for flare-ups: which medicines to increase, and exactly when to seek urgent care. Ask for one if you do not have it.

In India

In India, spirometry typically costs around ₹800–₹2,000 at private labs and hospitals, though prices vary by city and facility. A chest X-ray, if advised, usually adds a few hundred rupees — ask for the full estimate when the tests are ordered.

Spirometry quality depends heavily on the technician coaching you through it, so a reputed pulmonary function lab matters more than the cheapest option. NABL accreditation is a useful marker, and home sample collection in major cities covers the blood tests that sometimes accompany the workup.

Frequently asked questions

Advertisement

What is COPD and how is it classified?

COPD (chronic obstructive pulmonary disease) is a progressive lung condition causing persistent, largely irreversible airflow limitation. The GOLD classification stages it 1–4 by FEV1 percentage: GOLD 1 (mild, ≥80% predicted), GOLD 2 (moderate, 50–79%), GOLD 3 (severe, 30–49%) and GOLD 4 (very severe, below 30%).

Can you get COPD without smoking?

Yes. Alpha-1 antitrypsin deficiency (genetic), occupational exposure to dust and chemicals, and biomass fuel exposure from cooking fires cause COPD in non-smokers. About 15% of COPD occurs in never-smokers.

How is COPD different from asthma?

COPD is largely irreversible airflow obstruction caused mainly by smoking, while asthma involves reversible airflow limitation usually triggered by allergens or irritants. A bronchodilator reversibility test (spirometry before and after salbutamol) helps distinguish them: COPD shows minimal improvement, while asthma typically shows significant improvement.

Can COPD be cured?

COPD cannot currently be cured, but progression can be slowed. Smoking cessation is the single most effective intervention at any stage. Bronchodilators, inhaled corticosteroids, pulmonary rehabilitation and, in severe cases, long-term oxygen therapy improve quality of life and reduce exacerbation frequency.

How is a COPD exacerbation treated?

Exacerbations are treated with increased bronchodilator use, a short course of oral steroids, and antibiotics if sputum is purulent. Go to hospital if severe: oxygen saturation below 88%, confusion, inability to complete sentences, or failure to respond to home treatment. Discuss a written action plan with your doctor in advance.

I quit smoking years ago — can my COPD still get worse?
Quitting remains the best thing you did — it slows lung function decline at any stage. But COPD is a long-term condition that still needs monitoring, and flare-ups can happen. Keep your follow-ups and spirometry schedule, and discuss any worsening breathlessness with your doctor promptly.
Are inhalers addictive? I’m worried about using them for years.
Inhaled medicines are not addictive. Long-term use is about controlling a chronic condition, much like blood pressure tablets — the benefits and any risks are something to review with your doctor periodically. Correct inhaler technique matters more than most people realise, so ask to have yours checked.
Should I avoid exercise if I get breathless?
Breathlessness makes exercise daunting, but graded activity — often through a pulmonary rehabilitation programme — is recommended for most people with COPD. The key is a plan matched to your level. Discuss a safe exercise starting point with your doctor rather than avoiding movement altogether.
Why does my doctor keep asking about my heart?
COPD and heart disease share risk factors and can cause similar symptoms, particularly breathlessness and fatigue. Checking the heart is routine when evaluating COPD, not a sign that something extra is wrong. Mention any chest discomfort or ankle swelling at your visits.

References

Sources cited on this page. PubMed links open the original abstract.

  1. Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;12(12):CD005305. PMID 27930803 · doi:10.1002/14651858.CD005305.pub4
  2. Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023;61(4):2300239. PMID 36858443 · doi:10.1183/13993003.00239-2023
  3. Falsey AR, Becker KL, Swinburne AJ, et al. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note. Int J Chron Obstruct Pulmon Dis. 2012;7:127–135. PMID 22399852 · doi:10.2147/COPD.S29149
  4. MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology. 2021;26(6):532–551. PMID 33893708 · doi:10.1111/resp.14041
Medical Disclaimer: This page is for general education only and does not replace professional medical advice. Always consult a qualified healthcare provider.
Written and medically reviewed by Suman Konda, Clinical Pharmacist · Sources linked to PubMed · Not medical advice: see our disclaimer